ZIVO · Zivo Bioscience, Inc.
$0.67
At close · Nov 27
Going-concern doubt
— flagged Nov 14, 2025
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company's ability to continue as a going concern within one year after the date the financial statements are issued.”View the 10-Q filed Nov 14, 2025
Market Cap
$16.53M
Shares
3.89M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Andrew A. Dahl | Chief Executive Officer and Director | $2,960,134 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Andrew A. Dahl | Chief Executive Officer and Director | $240,000 |